... an increased growth inhibitory effect in both hepatocellular carcinoma (HEpG2) and lung cancer (A549) cells. When using synergistic drug combinations at corresponding dose levels, the calculation of ...
BOSTON (Reuters) - An experimental process that snags lung
cancer cells from a blood sample could give doctors real-time
feedback on the most effective therapy, researchers reported on
Wednesday.
... pump up the immune system to fight off a cancer, the new vaccine, Lucanix, is genetically engineered ... based in San Diego, consists of lung cancer cells that have been genetically altered to shut down ...
... of Energy's Argonne National Laboratory, researchers at The Scripps Research Institute, La Jolla, Calif., have for the first time solved the structure of a virus that can infect specific cancer cells.
... metastases. Focusing on macrophages, white blood cells that are key players in the immune response to foreign ... normal human lung epithelial cells, but is upregulated in human lung cancer, where a very ...
... Allgayer and her team focused on lung cancer cells' ability to metastasize. Indeed, the investigators ... u-PAR production using a genetic trick, the cells responded to cetuximab again.
"Our results show ...
... Drs. Loebinger and Janes chose the breast cancer cells for both models because in their in vitro ... test the engineered stem cells with other models, including lung cancer."
While not fully understood ...
... Institute investigator.
This finding was confirmed with additional experiments in mice that showed that lung cancer cells with tumor-initiating mutations in the genes KRAS and EGFR also depended on a ...
... directs Ohio State's Human Cancer Genetics program.
Using lung cancer cell lines, the investigators learned ... miR-21.
Last, the investigators took cells that had a mutated EGFR gene and treated them ...
... the team profiled a panel of 40 human lung cancer cell lines that had been characterized on the basis of EMT ... versus mesenchmyal) and site of origin (primary lung tumor versus metastasis), miR-200 ...
... effective targeted therapy exists for NSCL cancer tumors that harbor K-RAS mutations ... BEZ235 alone and found that it inhibits the proliferation of both lung cancer cells cultured in vitro and the growth ...
... a drug that would target this collection of proteins would be effective treatment for most lung cancers.
"This is the first statistically validated phosphopeptide signature to diagnose any disease, ...
... Lecia Sequist, MD, MPH, of the MGH Cancer Center, who led the study. “It is an exciting glimpse ... factor receptor (EGFR) on the surface of lung cancer cells, was approved in 2003 for treatment of NSCLC ...
... grown in the lab.
Significantly, transient inhibition of a separate kinase was effective in a lung cancer cell line which suggests that potent transient kinase inhibition may be effective in a ...
A new study by Ohio State University cancer researchers shows that boosting the level of a molecule ... Earlier research by the same investigators using lung cancer cells showed that miR-29b targets two ...
